• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

[心肌梗死后猝死和非猝死的相关因素]

[Factors in sudden and non-sudden death after myocardial infarction].

作者信息

Lascault G, Fillette F, Grosgogeat Y

机构信息

Service de Cardiologie, Hôpital de la Salpétrière, Paris.

出版信息

Presse Med. 1987 Sep 26;16(31):1533-7.

PMID:2889204
Abstract

Attempts at preventing total and sudden cardiac death after myocardial infarction can only succeed if its mechanisms and its contributing of determinant factors are known. It is now well established that sudden deaths account for one-half of mortality cases and that in the vast majority of cases these deaths are due to malignant ventricular arrhythmia. Several sudden death risk factors have been identified, including ventricular dysrhythmias, left ventricular dysfunction and myocardial ischaemia. A number of therapeutic trials on the prevention of post-infarction death have been conducted, but so far only beta-blockers have proved effective in reducing the incidence of total and sudden cardiac death. It is permissible to think, however, that other, discerningly selected treatments might also be effective.

摘要

只有在了解心肌梗死后心脏性猝死的机制及其决定性因素的情况下,预防心肌梗死后心脏性猝死的尝试才有可能成功。目前已经明确,猝死占死亡病例的一半,并且在绝大多数情况下,这些死亡是由恶性室性心律失常所致。已经确定了一些猝死危险因素,包括室性心律失常、左心室功能障碍和心肌缺血。已经进行了多项预防心肌梗死后死亡的治疗试验,但到目前为止,只有β受体阻滞剂被证明能有效降低心脏性猝死的发生率。然而,可以认为,其他经过精心挑选的治疗方法也可能有效。

相似文献

1
[Factors in sudden and non-sudden death after myocardial infarction].[心肌梗死后猝死和非猝死的相关因素]
Presse Med. 1987 Sep 26;16(31):1533-7.
2
[Stratification of arrhythmia risk and therapeutic options in survivors of acute myocardial infarction].[急性心肌梗死幸存者心律失常风险分层及治疗选择]
Rev Esp Cardiol. 1996 Mar;49(3):157-65.
3
[Secondary prevention of myocardial infarct with anti-arrhythmia drugs and beta receptor blockaders].
Wien Med Wochenschr. 1984 Dec 31;134(23-24):566-72.
4
[Betablockers, anti-arrhythmia and anti-ischemia agents and other drugs ... in the follow-up of myocardial infarction].
Arch Mal Coeur Vaiss. 1990 Sep;83(10):1497-9.
5
When is drug therapy warranted to prevent sudden cardiac death?何时有必要进行药物治疗以预防心源性猝死?
Drugs. 1991;41 Suppl 2:24-46. doi: 10.2165/00003495-199100412-00006.
6
[Can sudden death be prevented by drugs?].[药物能预防猝死吗?]
Schweiz Rundsch Med Prax. 1990 Sep 25;79(39):1142-8.
7
[Arrhythmia risk stratification in patients with heart failure according to drug treatment and its effects].[根据药物治疗及其效果对心力衰竭患者进行心律失常风险分层]
Ital Heart J Suppl. 2001 Dec;2(12):1278-83.
8
Overview of completed sudden death trials: US experience.已完成的猝死试验概述:美国的经验。
Cardiology. 1987;74 Suppl 2:24-31. doi: 10.1159/000174284.
9
Clinical trials of antiarrhythmic drugs in postmyocardial infarction and congestive heart failure patients.
J Cardiovasc Pharmacol Ther. 2001 Jan;6(1):99-106. doi: 10.1177/107424840100600110.
10
[Sudden death in heart failure. Analysis and prevention].[心力衰竭中的猝死。分析与预防]
Presse Med. 1992;21(1):33-8.